Search Results - "Freitas, Fatima R"

Refine Results
  1. 1

    Use of paclitaxel carried in lipid core nanoparticles in patients with late-stage solid cancers with bone metastases: Lack of toxicity and therapeutic benefits by Vital, Carolina G., Maranhão, Raul C., Freitas, Fatima R., Van Eyll, Brigitte M., Graziani, Silvia R.

    Published in Journal of bone oncology (01-06-2022)
    “…•LDE-PTX at 175 mg/m2/3wk dose was devoid of toxicity at > 3rd line treatment.•Among 18 LDE-PTX treated patients, 9 had PFS > 6 months and 2 had…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Thyroid hormone receptor β-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats by Villicev, Cássio M, Freitas, Fatima R S, Aoki, Marcelo S, Taffarel, Cássio, Scanlan, Thomas S, Moriscot, Anselmo S, Ribeiro, Miriam O, Bianco, Antonio C, Gouveia, Cecília H A

    Published in Journal of endocrinology (01-04-2007)
    “…It is well known that thyroid hormone affects body composition; however, the effect of the thyroid hormone receptor β (TRβ)-selective thyromimetic GC-1 on this…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Breakdown of the blood-ocular barrier as a strategy for the systemic use of nanosystems by Occhiutto, Marcelo L, Freitas, Fatima R, Maranhao, Raul C, Costa, Vital P

    Published in Pharmaceutics (14-05-2012)
    “…Several drug delivery systems have been proposed to overcome physiological barriers, improving ocular bioavailability. Systemic routes are seldom used due to…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Lipoprotein removal mechanisms and aging: implications for the cardiovascular health of the elderly by Maranhão, Raul C., Pala, Daniela, Freitas, Fatima R.

    “…The speed of removal from the plasma of apolipoprotein B-containing lipoproteins, for example, chylomicrons, VLDL and LDL is determinant of the plasma…”
    Get full text
    Journal Article
  11. 11

    Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: A possible mechanism for the reversal of atherosclerosis in the disease by Lang, Maria G, Vinagre, Carmen GC, Bonfa, Eloisa, Freitas, Fatima R, Pasoto, Sandra G, Brito, Tatiane S, Seguro, Luciana PC, Maranhão, Raul C, Borba, Eduardo F

    Published in Lupus (01-05-2022)
    “…Introduction The beneficial effect of hydroxychloroquine (HCQ) in decreasing LDL levels on Systemic Lupus Erythematosus (SLE) is well defined. The influence of…”
    Get full text
    Journal Article
  12. 12

    HDL metabolism and atheroprotection: predictive value of lipid transfers by Maranhão, Raul C, Freitas, Fatima R

    Published in Advances in clinical chemistry (2014)
    “…High-density lipoprotein (HDL) intravascular metabolism is complex, and the major HDL functions are esterification of cholesterol and reverse cholesterol…”
    Get full text
    Journal Article
  13. 13

    The Thyroid Hormone Receptor β‐Specific Agonist GC‐1 Selectively Affects the Bone Development of Hypothyroid Rats by Freitas, Fatima RS, Capelo, Luciane P, O'Shea, Patrick J, Jorgetti, Vanda, Moriscot, Anselmo S, Scanlan, Thomas S, Williams, Graham R, Zorn, Telma MT, Gouveia, Cecilia HA

    Published in Journal of bone and mineral research (01-02-2005)
    “…We investigated the effects of GC‐1, a TRβ‐selective thyromimetic, on bone development of hypothyroid rats. Whereas T3 reverted the IGF‐I deficiency and the…”
    Get full text
    Journal Article
  14. 14

    Paclitaxel Associated With Lipid Nanoparticles as a New Antiscarring Agent in Experimental Glaucoma Surgery by Occhiutto, Marcelo L, Freitas, Fatima R, Lima, Patrícia P, Maranhão, Raul C, Costa, Vital P

    “…To investigate the effects of paclitaxel associated with lipid nanoemulsions (LDE-PTX) on postoperative scarring in rabbits undergoing trabeculectomy…”
    Get full text
    Journal Article
  15. 15
  16. 16

    LIPID TRANSFER TO HDL IN PATIENTS WITH HEART FAILURE WAS DIMINISHED AND IS CORRELATED WITH SEVERITY OF THE DISEASE by Martinelli, Ana Elisa Marabini, Maranhao, Raul C, Carvalho, Priscila O, Curiati, Milena N.C, Tavoni, Thauany M, Freitas, Fatima R, Barretto, Antonio

    “…The study findings highlight the extensive involvement of the plasma lipids and HDL metabolism with HF presence and severity and the importance of elucidating…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Reduction of Atherosclerotic Lesions by the Chemotherapeutic Agent Carmustine Associated to Lipid Nanoparticles by Daminelli, Elaine N., Martinelli, Ana E. M., Bulgarelli, Adriana, Freitas, Fatima R., Maranhão, Raul C.

    Published in Cardiovascular drugs and therapy (01-10-2016)
    “…Purpose After injection in the bloodstream, a lipid nanoparticle (LDE) resembling low-density lipoprotein (LDL) concentrates in atherosclerotic lesions of…”
    Get full text
    Journal Article
  20. 20